transcriptome of cardiomyopathies Array lessons from the heart: focus on the genome and

[1]  Robert Tibshirani,et al.  Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. , 2004, Blood.

[2]  C. Ogilvie,et al.  Strategies for the rapid prenatal diagnosis of chromosome aneuploidy , 2004, European Journal of Human Genetics.

[3]  F. Penault-Llorca,et al.  DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. , 2004, Molecular human reproduction.

[4]  E. Kranias,et al.  Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy. , 2004, Biochemical and biophysical research communications.

[5]  N. Bowles,et al.  Genetics of inherited cardiomyopathies , 2004, Expert review of cardiovascular therapy.

[6]  C. Hsiung,et al.  Coupling multiplex RT-PCR to a gene chip assay for sensitive and semiquantitative detection of severe acute respiratory syndrome-coronavirus , 2004, Laboratory Investigation.

[7]  P. Brown,et al.  A specific gene expression program triggered by Gram-positive bacteria in the cytosol. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  I. Jurisica,et al.  Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis , 2004, International journal of cancer.

[9]  C. Scharff,et al.  Gene Expression Changes in the Course of Neural Progenitor Cell Differentiation , 2022 .

[10]  S. Henderson,et al.  Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma , 2004, Nature Genetics.

[11]  P. Brown,et al.  Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Cin,et al.  Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling , 2004, Genes, chromosomes & cancer.

[13]  Petri Auvinen,et al.  Are data from different gene expression microarray platforms comparable? , 2004, Genomics.

[14]  P. du Souich,et al.  Effect of hypoxia on cytochrome P450 activity and expression. , 2004, Current drug metabolism.

[15]  Tsz-Kwong Man,et al.  Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. , 2004, Nucleic acids research.

[16]  E. Olson.  A decade of discoveries in cardiac biology , 2004, Nature Medicine.

[17]  Javed Khan,et al.  Diagnostic Classification of Cancer Using DNA Microarrays and Artificial Intelligence , 2004, Annals of the New York Academy of Sciences.

[18]  M. Anderson.  Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? , 2004, Trends in cardiovascular medicine.

[19]  I. Kohane,et al.  Molecular classification of nemaline myopathies: “nontyping” specimens exhibit unique patterns of gene expression , 2004, Neurobiology of Disease.

[20]  Ken Garber,et al.  Gene Expression Tests Foretell Breast Cancer's Future , 2004, Science.

[21]  Carl Virtanen,et al.  Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles , 2004, The Lancet.

[22]  Raimond L Winslow,et al.  Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. , 2004, Genomics.

[23]  G. Baxter,et al.  Autocrine and paracrine actions of natriuretic peptides in the heart. , 2004, Pharmacology & therapeutics.

[24]  J. Cohn,et al.  Definition, classification, and staging of the adult cardiomyopathies: a proposal for revision. , 2004, Journal of cardiac failure.

[25]  R. Ferrari,et al.  Oxidative stress in cardiovascular disease: myth or fact? , 2003, Archives of biochemistry and biophysics.

[26]  F. Gallyas,et al.  Protective Effect of Amiodarone but Not N- Desethylamiodarone on Postischemic Hearts through the Inhibition of Mitochondrial Permeability Transition , 2003, Journal of Pharmacology and Experimental Therapeutics.

[27]  R. Lempicki,et al.  Evaluation of gene expression measurements from commercial microarray platforms. , 2003, Nucleic acids research.

[28]  R. Nichols,et al.  Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis. , 2003, Genome research.

[29]  D. Bell.  Heart failure: the frequent, forgotten, and often fatal complication of diabetes. , 2003, Diabetes care.

[30]  Huiling He,et al.  Microarray Analysis Uncovers the Induction of the Proapoptotic BH3-only Protein Bim in Multiple Models of Glucocorticoid-induced Apoptosis* , 2003, Journal of Biological Chemistry.

[31]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Atul J. Butte,et al.  Reproducibility of gene expression across generations of Affymetrix microarrays , 2003, BMC Bioinformatics.

[33]  J. Marx.  How to Subdue a Swelling Heart , 2003, Science.

[34]  J. Prestle,et al.  Ca(2+)-handling proteins and heart failure: novel molecular targets? , 2003, Current medicinal chemistry.

[35]  Francisco H Andrade,et al.  Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  V. Beneš,et al.  Standardization of protocols in cDNA microarray analysis. , 2003, Trends in biochemical sciences.

[37]  Isaac S Kohane,et al.  Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Iizuka,et al.  MECHANISMS OF DISEASE Mechanisms of disease , 2022 .

[39]  G. Dorn,et al.  Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. , 2003, The Journal of clinical investigation.

[40]  R. Moreno-Sánchez,et al.  Heart metabolic disturbances in cardiovascular diseases. , 2003, Archives of medical research.

[41]  Ulrike Mende,et al.  Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.

[42]  C. Semsarian,et al.  Hypertrophic cardiomyopathy: from gene defect to clinical disease , 2003, Cell Research.

[43]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[44]  M. Le Cunff,et al.  Transcriptomal analysis of failing and nonfailing human hearts. , 2003, Physiological genomics.

[45]  Stephen M. Hewitt,et al.  Post-analysis follow-up and validation of microarray experiments , 2002, Nature Genetics.

[46]  J. Towbin,et al.  Molecular diagnosis of myocardial disease , 2002, Expert review of molecular diagnostics.

[47]  Y. Capetanaki.  Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. , 2002, Trends in cardiovascular medicine.

[48]  L. Kunkel,et al.  Molecular profiles of inflammatory myopathies , 2002, Neurology.

[49]  Jianbo Li,et al.  The gene expression fingerprint of human heart failure , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Speed,et al.  Design issues for cDNA microarray experiments , 2002, Nature Reviews Genetics.

[51]  George C Tseng,et al.  Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. , 2002, Physiological genomics.

[52]  Paul D Allen,et al.  Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. , 2002, The American journal of pathology.

[53]  H. Vosberg,et al.  Low‐density DNA microarrays are versatile tools to screen for known mutations in hypertrophic cardiomyopathy , 2002, Human mutation.

[54]  J. D. Porter,et al.  A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. , 2002, Human molecular genetics.

[55]  D. Fatkin,et al.  Molecular mechanisms of inherited cardiomyopathies. , 2002, Physiological reviews.

[56]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[57]  H. Katus,et al.  Cardiomyopathies: from genetics to the prospect of treatment , 2001, The Lancet.

[58]  M. Dunn,et al.  Heart failure and apoptosis: Electrophoretic methods support data from micro‐ and macro‐arrays. A critical review of genomics and proteomics , 2001, Proteomics.

[59]  G. Dorn,et al.  Genetic Causes of Cardiac Hypertrophy Divergent Transcriptional Responses to Independent , 2022 .

[60]  John Quackenbush,et al.  Computational genetics: Computational analysis of microarray data , 2001, Nature Reviews Genetics.

[61]  S. Solomon,et al.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.

[62]  T. Tsunoda,et al.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. , 2001, Cancer research.

[63]  M B Eisen,et al.  Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  J. Seidman,et al.  The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.

[65]  D. Stamatiou,et al.  Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. , 2001, Biochemical and biophysical research communications.

[66]  L. Hawthorn,et al.  Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays , 2000, Circulation.

[67]  Eric P. Hoffman,et al.  Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology , 2000 .

[68]  James O. Mudd,et al.  An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy , 2000 .

[69]  T. Eulgem,et al.  The transcriptome of Arabidopsis thaliana during systemic acquired resistance , 2000, Nature Genetics.

[70]  A. Butte,et al.  Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Chien.  Genomic circuits and the integrative biology of cardiac diseases , 2000, Nature.

[72]  L. Fananapazir,et al.  Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. , 2000, Journal of molecular and cellular cardiology.

[73]  P. Kang,et al.  Apoptosis and heart failure: A critical review of the literature. , 2000, Circulation research.

[74]  L. Tavazzi,et al.  Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[75]  N. Weissman,et al.  Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin , 2000, The Journal of physiology.

[76]  M. Cremer,et al.  Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy , 2000, The Lancet.

[77]  E. Wolski,et al.  Normalization strategies for cDNA microarrays. , 2000, Nucleic acids research.

[78]  T. Borg,et al.  Specialization at the Z line of cardiac myocytes. , 2000, Cardiovascular research.

[79]  M. Givertz.  Underlying causes and survival in patients with heart failure. , 2000, The New England journal of medicine.

[80]  Kenji Nakamura,et al.  Cardiac fibrosis in mice lacking brain natriuretic peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Eric S. Lander,et al.  Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse , 2000, Nature Genetics.

[82]  T. Thum,et al.  Gene expression in distinct regions of the heart , 2000, The Lancet.

[83]  Y. J. Kang.  The antioxidant function of metallothionein in the heart. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[84]  S. Neubauer,et al.  Effects of ACE inhibition and β-receptor blockade on energy metabolism in rats postmyocardial infarction. , 1999, American journal of physiology. Heart and circulatory physiology.

[85]  G. Taffet,et al.  The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. , 1999, Journal of molecular and cellular cardiology.

[86]  H. Watkins,et al.  Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. , 1999, Cardiovascular Research.

[87]  N. Maulik,et al.  Apoptosis, Heart Failure, Ischemic Heart Disease , 1999, Heart Failure Reviews.

[88]  L. Mestroni,et al.  Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. , 1999, Journal of the American College of Cardiology.

[89]  K. Chien,et al.  Complexity in simplicity: monogenic disorders and complex cardiomyopathies. , 1999, The Journal of clinical investigation.

[90]  F. Follath,et al.  Nonischemic heart failure: epidemiology, pathophysiology, and progression of disease. , 1999, Journal of cardiovascular pharmacology.

[91]  J. Cleland,et al.  Heart failure due to ischaemic heart disease: epidemiology, pathophysiology and progression. , 1999, Journal of cardiovascular pharmacology.

[92]  K. Deisseroth,et al.  Calmodulin supports both inactivation and facilitation of L-type calcium channels , 1999, Nature.

[93]  F. Spinale,et al.  Controlling myocardial matrix remodeling: implications for heart failure. , 1999, Cardiology in review.

[94]  S. Tyagi,et al.  Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. , 1999, Journal of hypertension.

[95]  G. Dorn,et al.  Cardiac-specific Overexpression of Mouse Cardiac Calsequestrin Is Associated with Depressed Cardiovascular Function and Hypertrophy in Transgenic Mice* , 1998, The Journal of Biological Chemistry.

[96]  Maestri,et al.  The Failing Heart. , 1997, Advances in clinical pathology : the official journal of Adriatic Society of Pathology.

[97]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[98]  E. Maestrini,et al.  A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.

[99]  E. Sonnenblick,et al.  Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors. , 1995, The American journal of physiology.

[100]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[101]  L. Mestroni,et al.  A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. , 1995, The Journal of clinical investigation.

[102]  W. Parmley,et al.  Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts , 1995, Cardiovascular Drugs and Therapy.

[103]  F. Waagstein,et al.  Spectrum and outcome of congestive heart failure in a hospitalized population. , 1993, American heart journal.

[104]  D. Ingber,et al.  Mechanotransduction across the cell surface and through the cytoskeleton , 1993 .

[105]  J. Towbin,et al.  X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.

[106]  L. Peltonen,et al.  Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA , 1992, The Lancet.

[107]  A. Tajik,et al.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. , 1992, The New England journal of medicine.

[108]  R. Denton,et al.  The role of Ca2+ ions in the regulation of intramitochondrial metabolism and energy production in rat heart , 1989, Molecular and Cellular Biochemistry.

[109]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[110]  N. Green,et al.  Amino-acid sequence of a Ca2+ + Mg2+ -dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence , 1985, Nature.

[111]  L. Pickle,et al.  Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. , 1984, The American journal of cardiology.

[112]  A. de Haan,et al.  Calcium regulation and muscle disease , 2004, Journal of Muscle Research & Cell Motility.

[113]  A. Trounson,et al.  Towards preimplantation diagnosis of cystic fibrosis using microarrays. , 2004, Reproductive biomedicine online.

[114]  N. Alpert,et al.  Human heart failure: dilated versus familial hypertrophic cardiomyopathy. , 2003, Advances in experimental medicine and biology.

[115]  R. Schwinger,et al.  Modulation of SERCA: implications for the failing human heart , 2002, Basic Research in Cardiology.

[116]  J. Hill,et al.  Role of Metabolically Active Drugs in the Management of Ischemic Heart Disease , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[117]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[118]  G. Francis.  Changing the remodeling process in heart failure: basic mechanisms and laboratory results. , 1998, Current opinion in cardiology.

[119]  H. Katus,et al.  Frequency and phenotypes of familial dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[120]  P. Bornstein,et al.  Regulation of collagen gene expression. , 1989, Progress in nucleic acid research and molecular biology.